• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换术中供者的安全性。

Donor safety in plasmapheresis.

作者信息

Lundsgaard-Hansen P

出版信息

Dev Biol Stand. 1980;48:287-95.

PMID:7274560
Abstract

Whereas European authorities stipulate that a plasmapheresis donor should not give more than about 250 ml of plasma per week, American regulations continue to sanction a weekly "harvesting" volume of 1000 ml. The latter volume equals one third of a donor's plasma volume, and the loss of plasma proteins are identical with those of a patient suffering from a severe nephrotic syndrome. Accordingly, such donors develop hypoproteinemia, hypoalbuminemia, hypogammaglobulinemia, and abnormal electrophoretic patterns. Recent data give cause for concern with respect to evidence for an increased aggregating tendency of platelets. Pending the clarification of these problems, the necessary quantities of plasma should be procured by increasing the number of donors sufficiently to respect the European volume limitations.

摘要

欧洲当局规定,血浆置换捐献者每周捐献的血浆量不应超过约250毫升,而美国的规定仍允许每周“采集”1000毫升。后一量相当于捐献者血浆量的三分之一,血浆蛋白的损失与患有严重肾病综合征的患者相同。因此,这类捐献者会出现低蛋白血症、低白蛋白血症、低丙种球蛋白血症以及异常的电泳图谱。最近的数据令人担忧血小板聚集倾向增加的证据。在这些问题得到澄清之前,应通过充分增加捐献者数量来获取所需的血浆量,以遵守欧洲的量的限制。

相似文献

1
Donor safety in plasmapheresis.血浆置换术中供者的安全性。
Dev Biol Stand. 1980;48:287-95.
2
Observation of the changes of plasma proteins after long term plasmapheresis.长期血浆置换后血浆蛋白变化的观察
Dev Biol Stand. 1980;48:279-86.
3
Current plasmapheresis practices in the United States.
Dev Biol Stand. 1980;48:297-301.
4
Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.人类血液和血液制品的附加标准;原料血浆(人类)——食品药品监督管理局。最终规则。
Fed Regist. 1981 Nov 24;46(226):57480-1.
5
The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.不同强度的定期供体血浆置换对体液和细胞免疫、红细胞及铁代谢以及心血管风险标志物的影响。
Vox Sang. 2004 Apr;86(3):189-97. doi: 10.1111/j.0042-9007.2004.00408.x.
6
Anticoagulation, bleeding, and clotting at donor plasmapheresis.供体血浆置换术中的抗凝、出血与凝血
J Clin Apher. 2018 Aug;33(4):538-540. doi: 10.1002/jca.21626. Epub 2018 Mar 25.
7
A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).一项关于献血者长期强化血浆置换安全性的前瞻性多中心研究(SIPLA)。
Vox Sang. 2006 Aug;91(2):162-73. doi: 10.1111/j.1423-0410.2006.00794.x.
8
A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.一项前瞻性试验评估了在血浆置换过程中联合生理盐水输注采集多达 840 毫升血浆的安全性和有效性。
Transfusion. 2012 Aug;52(8):1806-13. doi: 10.1111/j.1537-2995.2012.03561.x. Epub 2012 Feb 20.
9
Management of plasmapheresis in France.法国血浆置换的管理
Hematol Cell Ther. 1996 May;38 Suppl 1:S25-33.
10
Current plasmapheresis practice in the United States.美国目前的血浆置换实践。
Ric Clin Lab. 1983 Jan-Mar;13(1):11-9. doi: 10.1007/BF02904741.

引用本文的文献

1
Analysis of influencing factors of serum total protein and serum calcium content in plasma donors.分析献血者血清总蛋白和血钙含量的影响因素。
PeerJ. 2022 Dec 9;10:e14474. doi: 10.7717/peerj.14474. eCollection 2022.